Business Description
Biotechnology Assets SA
NAICS : 325411
SIC : 2834
ISIN : ES0184980003
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.05 | |||||
Equity-to-Asset | 0.4 | |||||
Debt-to-Equity | 1.07 | |||||
Debt-to-EBITDA | 1.4 | |||||
Interest Coverage | 9.58 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 0.22 | |||||
Beneish M-Score | -1.54 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.1 | |||||
3-Year EBITDA Growth Rate | 52.1 | |||||
3-Year Book Growth Rate | 4.4 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.84 | |||||
9-Day RSI | 49.62 | |||||
14-Day RSI | 49.6 | |||||
6-1 Month Momentum % | -20.31 | |||||
12-1 Month Momentum % | -22.34 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.04 | |||||
Quick Ratio | 1.04 | |||||
Cash Ratio | 0.1 | |||||
Days Sales Outstanding | 250.63 | |||||
Days Payable | 1140.06 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -13.8 | |||||
Shareholder Yield % | 10.02 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 97 | |||||
Operating Margin % | 82.68 | |||||
Net Margin % | 43.67 | |||||
FCF Margin % | -7.75 | |||||
ROE % | 25.37 | |||||
ROA % | 9.01 | |||||
ROIC % | 12.41 | |||||
3-Year ROIIC % | -36.82 | |||||
ROC (Joel Greenblatt) % | 82.82 | |||||
ROCE % | 18.66 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 11.67 | |||||
PE Ratio without NRI | 11.25 | |||||
Price-to-Owner-Earnings | 12.6 | |||||
PS Ratio | 5 | |||||
PB Ratio | 2.72 | |||||
Price-to-Operating-Cash-Flow | 315 | |||||
EV-to-EBIT | 10.27 | |||||
EV-to-EBITDA | 5.3 | |||||
EV-to-Revenue | 7.51 | |||||
EV-to-FCF | -96.91 | |||||
Price-to-Median-PS-Value | 0.64 | |||||
Earnings Yield (Greenblatt) % | 9.74 | |||||
FCF Yield % | -1.38 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Biotechnology Assets SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 3.602 | ||
EPS (TTM) (€) | 0.027 | ||
Beta | 1.89 | ||
Volatility % | 16.32 | ||
14-Day RSI | 49.6 | ||
14-Day ATR (€) | 0.012785 | ||
20-Day SMA (€) | 0.31365 | ||
12-1 Month Momentum % | -22.34 | ||
52-Week Range (€) | 0.288 - 0.504 | ||
Shares Outstanding (Mil) | 64.34 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Biotechnology Assets SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Biotechnology Assets SA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Biotechnology Assets SA Frequently Asked Questions
What is Biotechnology Assets SA(XMAD:BST)'s stock price today?
When is next earnings date of Biotechnology Assets SA(XMAD:BST)?
Does Biotechnology Assets SA(XMAD:BST) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |